ArticleJournal of thoracic disease2025
Endovascular treatment outcomes for descending thoracic aortic pathologies in octogenarians: retrospective study.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Thoracic endovascular aortic repair (TEVAR) has become the reference treatment for thoracic diseases in high-risk patients. Regarding the aging of the population, the indications for TEVAR in octogenarians are constantly increasing with little data on the results of this treatment in this population. The aim of this study was to evaluate the short- and medium-term results of TEVAR for descending thoracic aorta diseases in octogenarians' patients. Methods: In a single-center retrospective study, patients aged 80 years and older who underwent TEVAR for descending thoracic aortic aneurysm or dissection between 2000 and 2021 were included. Demographic data, perioperative morbi-mortality, mortality risk factors, and anatomical results were analyzed using the latest available scanner during follow-up. Results: In this study from 2000-2021, 35 octogenarians' patients (57% men, 43% women) underwent treatment for thoracic aortic pathologies, 74% were treated for aneurysm, 26% for aortic dissection and 34% required urgent surgery (10 ruptures, 2 malperfusions). Technical success was 100%, with 14.0% intra-hospital mortality (4 respiratory distress, 1 cardiac arrest). Morbidity rate was 42% (7 respiratory complications, 2 paraplegias, 2 strokes, 3 renal failures). After 14 months of follow-up, death rate was 20% (6/30). Aortic diameter analysis showed stable lesions in 69.2% (n=18), regression in 26.9% (n=7), and increased diameter in 3.8% (n=1). Type I endoleaks were observed in 8.6% (n=3), type 2 in 11.4% (n=4). Conclusions: Endovascular treatment of descending thoracic aortic pathologies in patients aged 80 and older carries higher risks. Careful patient selection is crucial, and therapeutic abstention may be a viable option for this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.